Market Indices
Latest News
 |
Key Points- Holzer & Holzer, LLC is investigating Aquestive Therapeutics, Inc....January 9, 2026 AQST -37.09% |
| ||
| ||
| ||
|
Price Targets
from Goldman Sachs issued a price target of $3.50 for IHRT on 2026-01-09 10:01:28.The adjusted price target was set to $3.50.At the time of the announcement, IHRT...
January 9, 2026 IHRT -2.89%
David Kang from B.Riley Financial issued a price target of $18.00 for AXTI on 2026-01-09 05:31:00.The adjusted price target was set to $18.00.At the time of the announcement,
January 9, 2026 AXTI -12.20%
from Piper Sandler issued a price target of $18.00 for FENC on 2026-01-08 22:30:09.The adjusted price target was set to $18.00.At the time of the announcement, FENC...
January 8, 2026 FENC 2.11%
from Truist Financial issued a price target of $63.00 for DNTH on 2026-01-08 12:54:20.The adjusted price target was set to $63.00.At the time of the announcement, DNTH...
January 8, 2026 DNTH 0.49%
Michael Turrin from Wells Fargo issued a price target of $40.00 for VIA on 2026-01-08 11:53:56.The adjusted price target was set to $40.00.At the time of the announcement,
January 8, 2026 VIA -1.64%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| GP GreenPower Motor Company | 1.27
54.69% | ||||||||||||||||||
| KPLTW Katapult Holdings Equity | 0.00
44.12% | ||||||||||||||||||
| OPAD Offerpad Solutions Inc. | 2.16
42.11% | ||||||||||||||||||
| VXRT Vaxart, Inc. | 0.67
41.72% | ||||||||||||||||||
| VCIG VCI Global Limited | 0.94
38.07% | ||||||||||||||||||
| MREO Mereo BioPharma Group plc | 0.49
27.73% | ||||||||||||||||||
| DRTSW Alpha Tau Medical Ltd. Wa | 0.61
24.49% | ||||||||||||||||||
| IGTA Inception Growth Acquisit | 10.95
21.94% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 3.79%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 9.13%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -2.73%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.02%